Research & Development News
Top Research & Development News
-
News A Day in the Life of a Start-Up Founder and CEO
At CPHI we work to support Start-Up companies in the pharmaceutical industry and recognise the expertise and innovative angles they bring to the field. Through our Start-Up Programme we have gotten to know some of these leaders, and in this Day in the ... -
News Biopharmaceutical manufacturing boost part of new UK government budget
In their national budget announced by the UK Labour Party, biopharmaceutical production and manufacturing are set to receive a significant boost in capital grants through the Life Sciences Innovative Manufacturing Fund (LSIMF).
Research & Development news
-
News CPHI Podcast Series: The power of proteins in antibody drug development
In the latest episode of the CPHI Podcast Series, Lucy Chard is joined by Thomas Cornell from Abzena to discuss protein engineering for drug design and development. -
.png)
News Amgen sues Samsung biologics unit over biosimilar for bone disease
Samsung Bioepis, the biologics unit of Samsung, has been issued a lawsuit brought forth by Amgen over proposed biosimilars of Amgen’s bone drugs Prolia and Xgeva. -
News CPHI Podcast Series: Why we need to consider women in clinical trials
The latest episode of the CPHI Podcast Series with Lucy Chard covers women's health, specifically women's representation in clinical trials, the associated bias, and the impacts on health for this population. -
.png)
News US FDA does not approve MDMA therapy for PTSD, requests more data
The MDMA-based therapeutic developed by Lykos Therapeutics, a California-based Public Benefit Corporation (PBC), has been reviewed and unapproved by the US FDA. The regulator has requested additional phase III trial data for further safety and efficacy... -
.png)
News Novartis and Viatris latest facing lawsuit over HeLa cell misuse
Global pharmaceutical companies Novartis and Viatris are the latest hit with a lawsuit claim pertaining to alleged misuse of the ‘HeLa’ cell line from the estate of woman whose cancerous tissue cells were taken without consent. -
.png)
News Sanofi invests billions into Frankfurt insulin production site
French pharmaceutical company Sanofi have announced an investment of EUR1.3 billion at their existing BioCampus site in Frankfurt am Main for the expansion of insulin production. -
.png)
News Novel oral Type 1 diabetes drug gains US FDA IND designation
A University of Alabama at Birmingham startup has gained FDA clearance for Investigational New Drug clinical trials for an oral Type 1 diabetes drug, a milestone for diabetes treatment. -
News A Day in the Life of a Vice President in R&D & Engineering
In the Day in the Life of Series, we've already had the chance to get to know a range of people in various roles in the pharma industry. In the latest interview we get a glimpse into the R&D side of things from Jennifer Sorrells, Vice Presiden... -
.png)
News Second obesity drug candidate from Roche shows early trial success
Following from its purchase of Carmot Therapeutics, Roche have announced positive early-stage trial success for its second obesity drug candidate acquired from Carmot Therapeutics. -
News Tumour microproteins could provide basis for cancer vaccines
A recent study published in Science Advances has identified a set of microproteins produced exclusively in liver tumours, which may provide a clear target for the development of a cancer vaccine. -
.png)
News Reworked once-daily weight-loss pill from Pfizer to progress
American pharmaceutical giant Pfizer have continued with a reworked version of their weight-loss pill danuglipron, progressing with a once-daily version of the pill. -
News CPHI Podcast Series: the power of digital marketing in pharma
Digital marketing is a valuable tool for many industries, and the pharmaceutical and healthcare industry is no exception. The CPHI Podcast Series covers how marketing can be used by companies to increase their engagement and overcome challenges.&n... -
.png)
News Novel approach to creating sustainable packaging from rice husks
Researchers have created a new approach to the designing of eco-friendly nanofibres extracted from rice husks, addressing the critical need for sustainable packaging materials in food and biopharmaceutical products. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Identifying Alzheimer’s Disease biomarker proteins with whole blood tests
A University of Manchester spin-out pharmaceutical company, PharmaKure, has reported successful study results for the quantification of Alzheimer’s Disease biomarker proteins with a whole blood test. -
News Bill & Melinda Gates Foundation to boost mRNA vaccine initiatives in Africa with USD $40m
To address vaccine inequality and accessibility issues, the Bill & Melinda Gates Foundation aims to deliver USD $40m to various biotech companies and vaccine manufacturers in support of mRNA vaccine development. -
News CPHI Podcast Series: Exploring neurological frontiers in Alzheimer's and beyond
The next episode of the CPHI Podcast Series delves into the science and background behind some recent developments in the field of Alzheimer's disease and neurological disorders. -
News Is patient centricity the future of pharmaceutical manufacturing?
In this interview with Sandra Sánchez y Oldenhage, President of PharmAdvice, she speaks to the importance of considering patients in the manufacturing stages of the pharmaceutical supply chain, and how it can redefine healthcare. -
News CPHI Podcast Series: How to leverage AI for Drug Discovery
Artificial intelligence is the topic of debate in the latest episode from the CPHI Podcast Series, where Digital Editor Lucy Chard speaks with Bill Whitford of DPS Group about the integration of AI in healthcare. -
News Pfizer forges ahead with blood cancer therapy after approval from FDA
Pfizer gains accelerated approval from the US FDA for their new bispecific antibody therapy for multiple myeloma, set to address an unmet need for patients. -
News Alzheimer's drug donanemab deemed effective in landmark clinical trial
Results from the TRAILBLAZER-ALZ 2 Randomised Clinical Trial into the use of donanemab to treat early symptoms of Alzheimer’s disease have been analysed. -
News PSCI launches progressive position on the use of Horseshoe Crabs
A quarterly series of articles about responsible supply chain management from the PSCI. -
News Delivering on mRNA-based therapeutics: innovations in applications and packaging
Since the onset of the COVID-19 pandemic, the innovative potential of mRNA vaccines and therapeutics has raised questions regarding their manufacturing, packaging, and storage/transportation. Learn about how the pharmaceutical supply chain is meet... -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute. -
News Novavax will provide adjuvant Matrix-M for vaccine research with 3-year partnership
Novavax, developers behind the Matrix-M adjuvant, have entered into an agreement with the Bill and Melinda Gates Medical Research Institute to provide the adjuvant in preclinical vaccine research. -
News Thermo Fisher Scientific opens new steriles drug manufacturing site in Singapore
The life science service and instrument provider have opened their new Singapore-based steriles drug manufacturing facility with the goal of bringing increased development and manufacturing capabilities for critical medicines to the APAC region. -
News Medicines for All receive $18.7 million grant for expansion of global access to lifesaving medication
Funded by the Bill & Melinda Gates Foundation, the Virginia Commonwealth University-based research-related institute will use the grant to expand on its current capabilities of bringing lifesaving medications around the world, as well as working on 14 ... -
News Digital-first experimental approach to optimise drug formulations
Merck and XtalPi Inc. collaborate on an AI-powered technology platform to predict the crystal morphologies of diabetic medication metformin HCl, validated by wet-lab experiments conducted with Merck’s expertise, in a ‘digital-first’ a... -
News NextPharma acquisition of chewable tablet manufacturing site from Takeda complete
NextPharma has completed their acquisition of a Norway-based manufacturing site, specialising in chewable tablet technologies for calcium/vitamin D3 from pharmaceutical giant Takeda. -
News Pfizer and GSK spearhead development of promising RSV vaccines
Vaccines for RSV from GSK and Pfizer to be analysed by a panel of experts with a view to informing a decision from the US FDA on their approval. -
News CPHI Podcast Series: Rare Disease Day – Pharma fulfilling an unmet need
In this podcast Digital Editor Lucy Chard is joined by Rachel Smith of Parexel to discuss the challenges surrounding the development of medicines for rare disease patients. -
News Can we make clinical trials more diverse?
The US FDA are hoping to lead the way in addressing the lack of diversity and representation in clinical trials when developing medicines through new legislation. -
News CPHI Frankfurt 2022: Innovator Interview – DSM Biomedical
At CPHI Frankfurt we spoke to Anne-Cecile Bayne, Global Science & Innovation Lead Pharma and Medical Nutrition, and Marc Hendriks, Vice President Strategy & Business Development, on their expertise in nitrosamines and business strategy at DSM Biomedica... -
News New WHO health emergency guidelines expect full transparency from Big Pharma
The WHO are proposing a new set of pandemic guidelines to set out how future global health crises should be handled. -
.png)
News Magic mushrooms could be used to treat mental health conditions
A compound found in magic mushrooms, psilocybin, could be used to treat mental health conditions and help patients suffering with severe depression, as shown by the results of the largest study of its kind to date. -
News UK-based partnership to launch DETERMINE study into rare cancer research
UK-based CRO Quanticate is set to partner with Cancer Research UK for the launch of the DETERMINE study focused on testing a range of existing and approved drugs and therapies on rare cancers. -
News FDA approves Thermo Fisher blood tests for wheat and sesame allergies
Both tests have been approved by the US regulator for in vitro diagnostic use -
News QIAGEN launches world’s first syndromic test for monkeypox
The test can distinguish between monkeypox and other diseases that cause similar symptoms. -
News Monkeypox Update: Vaccine shortage, sewage surveillance and global testing
As concern over the monkeypox outbreak continues to rise, we take a look at major developments from the first week of August. -
News Could nanotech tattoos be the future of health monitoring?
Researchers in South Korea have developed an electronic tattoo that automatically signals potential health issues. -
News CPHI Podcast Series: The importance of novel excipients for innovative drug development
The latest episode in the CPHI Podcast Series dives into the world of novel excipients and explores their importance for innovative drug development. -
News Novel method for organoid production and storage to accelerate drug development research
Researchers develop method to produce organoid materials for disease and drug development research. -
News ‘Red flags’ spark concern over validity of key Alzheimer’s research
Serious concerns have been raised about the quality of landmark Alzheimer’s research, undermining commonly held beliefs about the disease -
News Amazon teams up with Fred Hutchinson to launch cancer vaccine clinical trial
Fred Hutchinson is sponsoring the Phase 1 trial, while Amazon are contributing scientific and machine learning expertise -
News South Korea's Seegene develops PCR test to detect monkeypox virus
Several countries are stepping up vaccination and testing as monkeypox cases continue to climb -
News EMA starts rolling review of Moderna’s Omicron-targeting vaccine, as well as Pfizer-BioNTech rival
The vaccines have been adapted to target the Omicron variant, which has been the dominant variant globally since the beginning of the year -
News Evotec enters drug discovery collaboration with Janssen Pharmaceutica NV
Evotec and Janssen Pharmaceutica team up to discover novel therapeutic candidates -
News BioNTech to start work on first African mRNA vaccine factory this month
The Rwanda site will be the first piece of the company’s African manufacturing network -
News Integrated service partners outperform standalone CDMOs in clinical development – Thermo Fisher
Engaging an integrated services partner could reduce risk and speed-up the process for drug sponsors. -
News Thermo Fisher and Charles River join consortium using robotics to produce cell therapies at scale
The Consortium aims to increase the scale of cell therapy manufacturing to a level impossible with current manual processes. -
News Onyx Scientific expands small molecule CMC services with new UK facility
The contract development and manufacturing organisation (CDMO) has completed the first phase of its multi-million-pound development. -
News Roche latest to report trial delays due to Ukraine war
The war in Ukraine has forced companies to suspend or delay clinical trials in the region. -
News Centring the patient experience - What pharma can learn from the consumer sector
What if unpacking medication could be as engaging as unboxing a new iPhone? Could design cues reassure the patient of drug integrity? Step-by-step opening signal ease of use, or empathetic design reduce patient anxiety? -
News AGC Pharma Chemicals to boost capacity by 30% at Spanish site
The expansion will increase production capacity for synthetic pharmaceutical products -
News Novartis presents promising new data on treatment for relapsing MS
Data showed that continuous treatment with Kesimpta was associated with fewer relapses and reduced risk of disability worsening -
News US FDA gives green light to UCB’s drug for rare childhood epilepsy
The FDA also granted paediatric exclusivity to the oral solution, branded Fintepla. -
News Ten23 health expands newly acquired sterile drug product manufacturing site
The expansion will provide additional cold storage and visual inspection capacity, as well as cleanrooms for device assembly and secondary packaging -
News Ukraine war expected to have long-lasting impact on clinical development
Many clinical trials have been put on hold or cancelled due to the war in Ukraine -
News Bristol Myers Squibb strikes $1.1B drug discovery deal with Volastra
Bristol Myers Squibb to leverage Volastra’s CINtech platform to discover and develop oncology drug candidates. -
News Seqens commits to US market with multi-million dollar investment in R&D
A redeveloped R&D facility will enhance Seqens' capabilities in developing and producing APIs and active delivery systems development -
News Lonza scoops contract to manufacture ovarian drug candidate for Oasmia
The CDMO will produce drug substance for clinical supply at its HPAPI manufacturing site in Nansha, China -
News CellCarta and physIQ join forces on personalised vaccines study
CellCarta and physIQ announce collaboration on study that could “revolutionise vaccine development.” -
News Lonza adds HPAPI manufacturing capabilities to its Nansha, China site
The development and cGMP manufacturing laboratories will provide additional early-phase HPAPI manufacturing capabilities -
News HCmed to expand inhalation treatment business with new CDMO offering
The Taiwan-based nebuliser specialist has signed an MoU with Formosa Laboratories, and Formosa Pharmaceuticals to form a biopharma one-stop-shop -
News OPTI-STEM Consortium receives financial boost to democratise access to cell therapy in France and Europe
Public funding of more than €7 million will help the project to find a solution to prohibitive production costs of developing stem cell-based therapies -
News Heidelberg Pharma and Huadong Medicine strike licensing and investment agreement
The multimillion-dollar deal focuses on potential targeted cancer treatments and makes Huadong the strategic partner in Asia for Heidelberg Pharma’s product development -
News Antimicrobial Resistance - Novel coalition sets out to tackle the next global health crisis
A diverse range of sectors and industries come together in partnership to address infection management, advocating a whole system approach -
News 2022 — a turning point for US biosimilars?
Cardinal Health says the majority of healthcare providers are keen to use biosimilars despite current market challenges -
News Piramal to create screening facility to boost in-vitro biology capabilities
The move is expected to bring added value to customers by coupling biology services with existing chemistry capabilities -
News Roquette to advance drug delivery research with new US Innovation Center
The new facility will focus on the research of excipients for oral dosage forms, drug delivery systems, nutraceutical APIs and innovative pharma ingredients -
News Hilleman Labs establishes Singapore's first pilot manufacturing facility for vaccine development
A 30,000-sq. ft cGMP facility and a separate R&D site will work alongside each other to provide end-to end product development solutions for Singapore and low- and middle-income countries -
News Sterling Pharma and MIB partner to develop low-cost route to new oral COVID drug
The new route uses a novel enzyme, cytidine aminotransferase, which would reduce the manufacturing cost of the drug -
News ANI Pharma enhances generics and CDMO business through Novitium acquisition
The transaction expands ANI’s R&D pipeline and adds nine new customers to its growing CDMO business -
News Matica Bio and Sartorius form large-scale vector production research pact
Together the companies will attempt to overcome "black box" challenges to enable more robust and consistent results for clients -
News Advanced Computing in Pharma: 3 reasons why quantum computing could disrupt R&D
Quantum computing technology uses quantum systems called “qubits”. They work with non-binary values, unlike classical computing which uses only bits with values of 0 or 1, and can overlap each other and act as a group. The result is a ... -
News GenScript ProBio to manufacture clinical trial batches of Synimmune's lead antibody drug
The CDMO will manufacture drug substance and drug product for Phase II clinical trials in AML patients -
News Thermo Fisher Scientific and AstraZeneca sign NGS-based CDx co-development agreement
Companies say earlier collaboration may speed development and introduction of targeted precision medicine therapies for patients. -
News COVID-19, patient needs and sustainability driving drug delivery tech innovation
Innovation is the cornerstone of the drug delivery technology sector; efforts to make therapies more convenient for patients, reduce side effects and differentiate products from the competition have always made the delivery sector a hotbed of new ideas... -
News Samsung Biologics and Kineta strike cancer immunotherapy development and manufacturing deal
Samsung to provide end-to-end CDMO services to advance Kineta's novel anti-VISTA antibody for the treatment of solid tumours -
News Catalent enters CBD anaesthetic product formulation project
The company will use its orally disintegrating tablet technology Zydis for JOS Pharmaceuticals' licensed CBD product -
News Sanofi to accelerate mRNA vaccines through new Center of Excellence
The company will invest €400 million per year to advance mRNA technology beyond the pandemic -
News Genezen begins construction of cGMP lentiviral production facility
The investment will provide capacity to support current and future demands for the rapidly evolving cell and gene therapy sector -
News Vectura to provide preclinical support for Incannex's inhaled brain injury treatment
IHL-216A may make sports safer and reduce the morbidity and mortality rates of people suffering serious head traumas -
News ProBioGen and LAVA Therapeutics sign cell line development agreement
The agreement marks the second cell line development collaboration between the two companies -
News Coriolis Pharma expands facilities for ATMP development
The expansion close to company's Martinsried headquarters includes a lyophilisation development centre for advanced therapy medicinal products -
News Construction underway for Yposkesi's second commercial bioproduction site
The French CDMO is also creating a new global resource for drug developers of ATMPs -
News Drug delivery start-ups recognize benefits of contract manufacturing: CPHI panel
Strong and effective partnerships with CDMOs are essential to success due to the complexity of manufacturing processes -
News Inclusion is everything: expanding diversity in clinical trials
How is the pharmaceutical industry tackling the issue of ensuring minority populations are properly represented in clinical trials? -
News Abzena to build US biologics manufacturing plant in North Carolina
New facility will be research partnering company’s sixth global site and will be dedicated to mammalian biologics -
News TCR2 bets on lead candidate with new cell therapy manufacturing facility
The US facility in Rockville is expected to accelerate the company’s commercial-scale manufacturing timelines of gavo-cel -
News China's Raybow Pharmaceuticals invests $15.8 million to expand US facility
The company will triple its capacity and workforce at its North Carolina site to increase its global capabilities and reach -
News Artificial intelligence a no-brainer for drug discovery
AI is helping pharma find the drug candidates with the greatest chance of success, according to experts who say therapeutic efficacy and cost reduction are the key dynamics -
News Adaptive clinical trial success calls for flexible approach
Adaptive clinical trials have accelerated COVID-19 vaccine development and could make drug R&D more efficient but running such studies is complex and challenging and sponsors need to prepare, say experts -
News Clinical Development Success Rates and Contributing Factors 2011-2020: New Report from Informa Pharma Intelligence
Biologic products advance through clinical development with a higher success rate than traditional small molecules, this new analysis of clinical development success from Informa Pharma Intelligence, the Biotechnology Industry Organization and the... -
News Lonza to develop and manufacture Ixogen's oncolytic virus
PsiVac has generated compelling efficacy data in killing a broad range of tumour cells, including head and neck, bladder, liver, pancreatic and ovarian -
News CPHI Podcast Series: Decentralised Clinical Trial Design - Collecting Real World Data in a Remote Setting
In this podcast interview with Fabien Du Fraisse and Deepu Joseph at Quanticate, we delve into the trend of decentralising clinical trials -
News Regis completes expansion of US-based API development facility
The CDMO doubles its capacity to take on new development projects -
News Lonza boosts solid form services for small molecule APIs
The expanded and refined first-in-human services have been designed to meet the early-stage molecule development of small biopharma players -
News Phlow secures $20 million to advance manufacturing initiatives in the US
The company seeks to actively accelerate US manufacturing for medicines at risk of shortage, including those for COVID-19 pandemic response -
News Catalent secures Trizell cell therapy development and manufacturing contract
The agreement allows the CDMO to "stay on the forefront of emerging indications and cell types" -
News Clinical knowledge deficits to slow biotech development, warns Europital
The CRO predicts investment communities will come to the rescue of small and medium companies looking to advance their candidates -
News Argonaut Manufacturing Services opens custom controls & standards facility
The CMO has designed the new service to alleviate manufacturing challenges associated with positive controls and nucleic acid templates -
News Sepha launches small batch contract packaging service amid rising demand
The CPO's new division will offer a holistic blister packaging development service, complete with QA and non-destructive leak testing, encompassing material selection, tooling design, and 3D prototyping -
News EU delivers export threat after AstraZeneca cuts Q1 vaccine supply
European Commission pressures pharma firm over reduced shipments amid criticism for slow vaccine rollout across block -
News Emergent to manufacture Humanigen COVID-19 therapeutic
The CDMO gears up for rapid deployment of its clinical-to-commercial manufacturing operations for its seventh collaboration to help deliver COVID-19 treatments -
News Oxford University to create institute to fight antimicrobial resistance after Ineos donation
The donation from Ineos will create a new institute to tackle the "silent pandemic" -
News Vectura expands capabilities to develop highly potent inhaled drugs
The expansion will enable the CDMO to widen the nature of inhaled drug development projects it can undertake for customers -
News Catalent starts manufacture of Passage Bio's lead gene therapy products
The CDMO will provide packaging, labeling and distribution services through its FastChain demand-led supply offering -
News Lonza expands development and manufacturing capabilities at Bend site
The company will invest in dedicated early-phase development and cGMP manufacturing to help customers rapidly advance challenging molecules -
News AZ and Oxford COVID-19 vaccine brings end of pandemic a little closer
AZD1222 is 90% effective, cheap to produce and easy to store, distribute and administer -
News Alvotech and Yangtze River forge biosimilar deal for Chinese market
The partnership will focus on commercializing eight biosimilar medicines in China for the domestic market -
News Early trial results hail Moderna's COVID-19 vaccine as 94.5% effective
Data also show that mRNA-1273 remains stable at 2–8°, the temperature of a standard home or medical refrigerator, for 30 days. -
News European Commission wraps up CureVac COVID-19 vaccine supply deal
Europeans set to benefit from the EC's authorization of COVID-19 candidate vaccine supply agreement, securing up to 405 million doses of CVnCoV -
News Vibalogics establishes US presence with virotherapy facility in Boston
The specialist CDMO's $150 million 3-year investment plan will provide a complete suite of virotherapy services to support drug developers and their most "revolutionary" products. -
News Pill Connect secures £0.5m to take electronic smart pill bottle to commercial launch
Device provides clinicians and trialists with comprehensive data on a patient's adherence pattern. -
News Sanofi and GSK to support COVAX with 200 million doses of COVID-19 vaccine
The companies anticipate first results of Phase I/II in early December 2020, to support the initiation of a pivotal Phase III study before the end of the year. -
News Russia submits Sputnik V emergency use and prequalification application to WHO
The Russian Federation has become one of the first countries to apply to the WHO for prequalification of its vaccine, Sputnik V, against the novel coronavirus infection. -
News Vaccine manufacturing demand has had limited effect on regenerative medicine sector, panel tells CPHI audience
The ramping up of vaccine manufacturing demand amid the COVID-19 pandemic had an initial impact on cell and gene therapy production but the regenerative medicine sector has largely weathered the storm, according to senior industry figures in a recent p... -
News Sai Life Sciences to boost biology capabilities at its integrated R&D campus
The CRDMO will expand in vitro and in vivo biology services, DMPK and toxicology capabilities. -
News RedHill Biopharma secures expanded manufacturing for COVID-19 therapeutic candidate
The biopharma company collaborates with European and Canadian suppliers for large-scale ramp-up of opaganib manufacturing.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance